Kprx marketwatch
WebKPRX Kiora Pharmaceuticals Inc. Annual Income Statement MarketWatch Kiora Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest KPRX financial statements, income... WebKPRX Kiora Pharmaceuticals Inc. Annual Income Statement - WSJ Subscribe Sign In Kiora Pharmaceuticals Inc. KPRX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 …
Kprx marketwatch
Did you know?
WebThe company was founded by Sébastien St. CEO Charles Bowman Employees 689 Headquarters Gatineau, Québec Founded 2013 HEXO Key Statistics Market cap 51.58M Price-Earnings ratio -0.24 Dividend yield — Average volume 1.11M High today $1.44 Low today $1.18 Open price $1.25 Volume 3.64M 52 Week high $8.38 52 Week low $0.9006 … Web11 apr. 2024 · KPRX Price Target 2024 Kiora Pharmaceuticals Analyst Ratings Free Trial NASDAQ:KPRX Kiora Pharmaceuticals - KPRX Price Target & Analyst Ratings $3.50 -0.12 (-3.31%) (As of 04/11/2024 10:46 AM ET) Compare Today's Range $3.49 $3.66 50-Day Range $3.28 $6.94 52-Week Range $2.32 $26.20 Volume 4,509 shs Average Volume …
Web11 apr. 2024 · KIORA PHARMACEUTICALS, INC. : Noticias, novedades e información acción KIORA PHARMACEUTICALS, INC. KPRX US49721T3095 Nasdaq Web12 apr. 2024 · According to 9 analysts, the average rating for KPRX stock is "Buy." The 12-month stock price forecast is $47.94, which is an increase of 1,220.66% from the latest price. Price Target $47.94 ( 1,220.66% upside) Analyst Consensus: Buy Stock Forecasts News All Videos Press Releases Conversation
WebKPRX Kiora Pharmaceuticals Inc. Annual Balance Sheet MarketWatch Kiora Pharmaceuticals Inc. Annual balance sheet by MarketWatch. View all KPRX assets, cash, debt, liabilities,... WebComplete Kiora Pharmaceuticals Inc. stock information by Barron's. View real-time KPRX stock price and news, along with industry-best analysis.
Web29 mrt. 2024 · KPRX:NAQ price moved over +1.22% to 3.33 March 24, 2024 Chart not available Key statistics As of last trade, Kiora Pharmaceuticals Inc (KPRX:NAQ) traded at 3.53, 51.94% above the 52 week low of...
WebKPRX Complete Kiora Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical … KPRX Options Stock Screener Earnings Calendar Sectors Nasdaq KPRX U.S.: … View the KPRX U.S. Securities and Exchange Commission reporting … 宝玉 リンクWebKiora Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. KPRX updated stock price target summary. 宝玉 フィールド魔法 サーチWeb12 apr. 2024 · Kiora Pharmaceuticals (NASDAQ:KPRX) has a market capitalization of $6.34 million and generates $10,000.00 in revenue each year. The company earns $-13,580,000.00 in net income (profit) each year or ($55.23) on an earnings per share basis. bub100r オムロンWeb6 apr. 2024 · Short interest is the volume of Kiora Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 48,300 shares of KPRX short. 2.86% of Kiora Pharmaceuticals' shares are currently sold short. Learn More on Kiora Pharmaceuticals' current short interest. 宝石の国 ゴースト 呪いWebKPRX Kiora Pharmaceuticals Inc. Analyst Estimates & Rating – WSJ Kiora Pharmaceuticals Inc. KPRX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/31/23 $3.34 USD -0.09 -2.62%... bub100re オムロンWebKPRX - Kiora Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly … bub100re バッテリーWeb22 nov. 2024 · Kiora Pharmaceuticals Completes Enrollment of Clinical Trial Evaluating KIO-201 for Persistent Corneal Epithelial Defects; Results Expected to be Reported in 1H 2024 Newsfile Corp. 07:02 AM ET. Wednesday, Dec 14, 2024. 宝石パフェ 診断